Patents by Inventor PULMAGEN THERAPEUTICS (ASTHMA) LIMITED

PULMAGEN THERAPEUTICS (ASTHMA) LIMITED has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130225617
    Abstract: Compounds of the invention are ligands of the CRTH2 receptor, useful inter alia for treatment of inflammatory conditions.
    Type: Application
    Filed: January 31, 2013
    Publication date: August 29, 2013
    Applicant: PULMAGEN THERAPEUTICS (ASTHMA) LIMITED
    Inventor: PULMAGEN THERAPEUTICS (ASTHMA) LIMITED